Power Law company profile

Harrow Health | Imprimis Pharmaceuticals

Health Tech & Medtech · Nashville, United States · Founded 2011 · IPO 2013 Unicorn

Ophthalmic-focused pharmaceutical compounding and drug commercialization services

Valuation

$1.69B

Market cap · May/2026

Revenue

$272M

Latest reported FY

EBITDA

$50M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Global footprint

Where Harrow Health | Imprimis Pharmaceuticals has talent and traffic

Workforce by country

🇺🇸 United States · Nashville HQ

Book a demo for the full country breakdown

Web traffic by country

15K monthly visits
across markets

🇺🇸 United States34.7%

🇨🇦 Canada24%

🇬🇧 United Kingdom12.7%

🇪🇸 Spain11.3%

🇮🇳 India10.7%

Top 5 markets shown

Market sentiment

What the market is saying about Harrow Health | Imprimis Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Harrow Health | Imprimis Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Harrow Health | Imprimis Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles